A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Add-On to Standard-of-Care Study of n-Butylphthalide (NBP) Softgel Capsules for Treatment of Mild to Moderate Cortical Acute Ischemic Stroke (AIS) in Adult Subjects
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Butylphthalide (Primary) ; Aspirin
- Indications Stroke
- Focus Adverse reactions
- Sponsors CSPC Ouyi Pharmaceutical
- 03 Apr 2017 Planned End Date changed from 1 Dec 2019 to 1 Jun 2020.
- 03 Apr 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Mar 2020.
- 03 Apr 2017 Planned initiation date changed from 1 May 2017 to 1 Jun 2017.